WALTHAM, Mass. -- Decision Resources, Inc., a leading research and advisory firm focusing on pharmaceutical and healthcare issues, forecasts that the HIV drug market will grow to more than $8 billion by 2013. Novel therapeutic classes that augment treatment options for the treatment-experienced population will drive the market.
The new Pharmacor study, titled "Human Immunodeficiency Virus," finds that,
despite advances in therapy, the HIV drug market is constrained by social and
political pressures on the pharmaceutical industry.
"HIV is a highly politically and socially charged disease, this factor has
important implications for drug developers," said Aarti Raja, PhD, an analyst with
Decision Resources. "Pharmaceutical manufacturers have been under increasing
public pressure to address the global HIV crisis by drastically reducing drug
prices for developing countries. Beyond the profitability concerns directly
related to the developing world, manufacturers worry that the high price
differentials created by such a move may increase price pressure in the major
markets."
Since its identification in the early 1980s, HIV has become one of the
most serious epidemics of modern times and a significant source of morbidity,
mortality, and cost to society. Beginning in the late 1980s, advances in the
understanding and treatment of HIV, particularly the development of highly
active antiretroviral therapy (HAART), have substantially halted the
progression of HIV and reduced mortality from AIDS.
Source: Decision Resources, Inc.
Dear Helpdesk: Working in a Toxic Health Care Environment
March 28th 2024Dear Helpdesk is your steadfast companion, offering life coaching and workplace advice from 2 seasoned IPs for some of your most challenging real-life situations. Let us help you navigate the intersection between work and life, guiding you to navigate the dynamic world of infection prevention with confidence and grace. This article is on handling a toxic health care environment.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.